Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis

Journal of Hepatology

Volumn 34, Issue 6, 2001, Pages 903-910

  Marzano, Alfredo ^a   Salizzoni, Mauro ^b   Debernardi Venon, Wilma ^a   Smedile, Antonina ^a   Franchello, Alessandro ^b   Ciancio, Alessia ^a   Gentilcore, Elena ^a   Piantino, Paolo ^c   Barbui, Anna Maria ^c   David, Ezio ^a   Negro, Francesco ^d   Rizzetto, Mario ^a  

^a Azienda Molinette ^*  (Italy)

^b Liver Transplantation Center   (Italy)

^c Institute of Microbiology   (Italy)

^d UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Antiviral therapy; Cirrhosis; Hepatitis B virus immune globulin; Lamivudine; Liver transplantation; Prophylaxis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; HEPATITIS B ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; METHYLPREDNISOLONE; STEROID; TACROLIMUS; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; HUMAN TISSUE; IMMUNOPROPHYLAXIS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT INFECTION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; LAMIVUDINE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE;

EID: 0034948689     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00080-0     Document Type: Article

References (22)

1. Liver transplantation in European patients with the hepatitis B surface antigen
2. Impact of immunoprophylaxis and patient selection on outcome of transplantation for HbsAg-positive recipients
3. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients
4. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis
5. Hepatitis B virus mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis
6. Recurrence of hepatitis B in liver transplants treated with antiviral therapy
7. Pre-transplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B related end-stage liver disease
8. Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation
9. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis
10. High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation
11. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin
12. Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation
13. Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin
14. Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin
15. Transection of the oesophagus for bleeding oesophageal varices
16. Histological grading and staging of chronic hepatitis
17. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy
18. Multiple sequence alignment with hierarchical clustering
19. The avidin-biotin complex in affinity cytochemistry
20. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine
21. Prophylaxis in liver transplant recipients using a fixing dosing schedule of hepatitis B immunoglobulin
22. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization